THE DEAL, AT A GLANCE
2/4 explanations supportedOne Biosciences
One Biosciences
One Biosciences makes cell-by-cell tumor maps and clinician-ready reports from preserved or frozen samples.
01What it doesOne Biosciences makes cell-by-cell tumor maps and clinician-ready reports from preserved or frozen samples.Source-grounded · automated review · Explore ↗
02Who is involvedEvidence still neededOpen review status ↗
The draft makes no investor claim and correctly states that the provided source document does not name Series A investors or investor roles.
03What happenedEvidence still neededOpen review status ↗
The draft correctly rejects the financing event: the provided document does not establish a Series A announcement, date, amount, currency, valuation, round, arranger, lender, or completed financing.
04Why it mattersIts service aims to make detailed single-cell tumor data usable in real-world clinical studies.Interpretation · Explore ↗
Click a part to explore its evidence. The image is supplied by the cited source.Original record source ↗
One Biosciences · Financing Record
Explore source-linked visual explanations for One Biosciences. Unsupported claims are withheld while source review continues.
Record 12158 · Recorded date: 2026-09-11
Explore company records →